Prime Peptides

Prime Peptides is a research compound supplier with 21 active listings on Peptides.SO, offering a catalog that spans GLP receptor agonist compounds, growth hormone-axis peptides, tissue healing agents, anti-aging and longevity compounds, metabolic research agents, and cosmetic-science peptides. The company's catalog features notable breadth for its listing count, with specialty entries including a TB-500 capsule format (TB4-Frag 17-23, 250mcg/capsule) that represents an alternative delivery format for thymosin beta-4 fragment research.

The GLP receptor research segment covers the major contemporary compounds. Semaglutide (GLP-1 receptor agonist) and Tirzepatide (dual GLP-1R/GIPR agonist) are listed for metabolic biology, adipose tissue signaling, and incretin pharmacology research. Retatrutide (triple GLP-1R/GIPR/GCGR agonist) extends the catalog into frontier triple-receptor biology research, where glucagon receptor co-agonism adds an additional hepatic lipid metabolism and energy expenditure dimension to the GLP pharmacology profile.

The growth hormone-axis segment includes Sermorelin (GHRH 1-29 analog for pulsatile GH research), Tesamorelin (44-amino acid GHRH analog for body composition research), CJC/Ipamorelin blend (standard GHRH/GHRP combination for GH secretagogue research), and CJC-No DAC/Ipamorelin Blend (5mg/5mg). These options serve researchers with varying study designs requiring either standard or precise-dose combination formulations.

Prime Peptides' verified per-mg anchor points: GHK-Cu at $0.63/mg (120mg), Melanotan I at $4.50–$5.00/mg (10mg). The remainder of the catalog uses blend formats (KLOW, GLOW) or capsule delivery systems (TB4-Frag 17-23, NAD+, 5-Amino-1MQ) that are not directly comparable on a per-mg basis to standard lyophilized vials.

TB-500 in capsule form (TB4-Frag 17-23, 250mcg/capsule) is a distinctive catalog entry. The Fragment 17-23 of Thymosin Beta-4 represents the active actin-binding domain, studied specifically for its effects on cell motility, wound healing promotion, and tissue repair signaling — the capsule format provides an alternative to injectable reconstituted vials for oral-administration research designs in appropriate experimental contexts.

The anti-aging and longevity segment includes AOD-9604 (growth hormone Fragment 176-191 for lipolysis research), MOTS-c (mitochondria-derived peptide for metabolic adaptation and insulin sensitivity research), NAD+ (nicotinamide adenine dinucleotide for cellular energy metabolism research), and the PCL GLOW Blend (a pharmaceutical-compounding-laboratory cosmetic peptide formulation). GHK-Cu (120mg, blue/purple color) addresses copper peptide and wound healing biology. Klow Blend (80mg) combines BPC-157, TB-500, KPV, and GHK-Cu for multi-compound tissue repair studies. 5-Amino-1MQ covers NAD+ metabolism and adipocyte biology research. Semax covers neuroprotective and cognitive enhancement research. Melanotan I supports photoprotection and pigmentation biology. Bacteriostatic water (30mL, limited availability) is available for reconstitution. All Prime Peptides products are sold exclusively for laboratory and in-vitro scientific research and are not intended for human or veterinary use.